Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-31 @ 3:02 PM
Study NCT ID:
NCT01239758
Status:
TERMINATED
Last Update Posted:
2013-02-01
First Post:
2010-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy
Sponsor:
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A031-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None